RemeGen Co., Ltd.
REGMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.54 | 1.26 | 0.16 | -0.10 |
| FCF Yield | 2.00% | -0.74% | -3.72% | -6.21% |
| EV / EBITDA | -247.25 | -195.86 | -47.41 | -23.68 |
| Quality | ||||
| ROIC | -2.03% | -3.73% | -5.44% | -8.43% |
| Gross Margin | 84.52% | 84.79% | 83.26% | 79.93% |
| Cash Conversion Ratio | -4.55 | 0.29 | 0.74 | 0.70 |
| Growth | ||||
| Revenue 3-Year CAGR | 20.17% | 34.92% | 34.26% | 30.52% |
| Free Cash Flow Growth | 139.93% | 36.53% | 38.56% | -586.70% |
| Safety | ||||
| Net Debt / EBITDA | -12.88 | -13.21 | -11.87 | -5.82 |
| Interest Coverage | -6.13 | -9.78 | -12.61 | -24.49 |
| Efficiency | ||||
| Inventory Turnover | 0.15 | 0.14 | 0.14 | 0.15 |
| Cash Conversion Cycle | 535.24 | 535.37 | 558.60 | 549.22 |